Delivery Order SPE2DB24D2010-SPE2DB25FABFT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $25,277.89 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 9, 2025, with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $15,872.15 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 15, 2025, with completion expected by September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,247.90 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on July 16, 2025, with completion scheduled for July 17, 2025. This competitive, non-set-aside delivery order represents a firm fixed-price transaction for pharmaceutical supply. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $4,771.95 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 29, 2025, with completion scheduled for July 30, 2025. This non-competitive delivery order represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a $42,420.50 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical supply delivery to support military healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,544.19 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) with a firm fixed price structure. This non-set-aside contract was competitively awarded and is scheduled for completion by September 29, 2025. The order will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,175.66 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (quantity: 8 units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $35,332.72 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitive award, executed under firm fixed pricing with no set-aside designation, leverages AmerisourceBergen's established pharmaceutical distribution capabilities to support federal medical procurement needs. The delivery will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,107.17 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on June 2, 2025, with an ultimate completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- The Defense Logistics Agency awarded a $11,453.04 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This is a firm fixed-price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 2, 2025. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement requirements in open competition. This...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABFTDelivery Order
The Defense Logistics Agency (DLA) awarded a $40,900.74 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on September 16, 2025, with an ultimate completion date of September 17, 2025. The award was made on a competitive, non-set-aside basis under a firm fixed-price contract structure. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The place of performance is the company's corporate office location in Conshohocken, PA. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp demonstrates significant capability in meeting federal procurement requirements through its extensive portfolio of medical product deliveries, which encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.9k | 9/16/25 |